Literature DB >> 8481554

Fecal excretions of hydroxy fatty acid and bile acid in diabetic diarrheal patients.

T Nakamura1, K Imamura, F Kasai, F Tsushima, H Kikuchi, K Takebe.   

Abstract

Thirteen normal subjects, 5 diarrheal controls (Group I) and 13 diabetics without peripheral neuropathy (Group II) were compared with 7 diabetic patients (Group III) with respect to fecal excretions of bile acids and hydroxy fatty acids for pathogenesis of diabetic diarrhea. The mean fecal excretions of bile acids per day were 304.9 mg for the normal controls, 297.8 mg for Group I, and 382.4 mg for Group II, while those of Group III were significantly higher (958.2 mg, p < 0.01) than the foregoing groups, and nearly three times as much as the controls. As to the fecal fatty acid excretion, there were no significant differences observed among these groups. The percentages of fecal hydroxy fatty acids were not significantly different in normal subjects (1.5%), Group I (2.0%), and Group II (1.2%). In contrast, the percentage of hydroxy fatty acid for Group III was greatly (p < 0.01) increased (13.2%). From the above results, the percentage of hydroxy fatty acid in diabetic diarrheal patients was high, suggesting that there is bacterial overgrowth. Meanwhile, the fecal bile acid level was increased about three times, indicative of poor absorption of bile acid from mild to moderate degree. Therefore, it is considered improbable that fecal hydroxy fatty acids and bile acids are the cause of diabetic diarrhea.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8481554     DOI: 10.1016/1056-8727(93)90017-s

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  8 in total

1.  Effect of bile salts on colonic mucus secretion in isolated vascularly perfused rat colon.

Authors:  A Barcelo; J Claustre; F Toumi; G Burlet; J A Chayvialle; J C Cuber; P Plaisancié
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

Review 2.  Lipid-mediated muscle insulin resistance: different fat, different pathways?

Authors:  Olesja Ritter; Tomas Jelenik; Michael Roden
Journal:  J Mol Med (Berl)       Date:  2015-06-25       Impact factor: 4.599

3.  No negative feedback regulation between plasma CCK levels and luminal tryptic activities in patients with pancreatic insufficiency.

Authors:  T Nakamura; K Takebe; K Kudoh; M Ishii; K Imamura; H Kikuchi; F Kasai; Y Tandoh; N Yamada; Y Arai
Journal:  Int J Pancreatol       Date:  1995-02

4.  Effects of high-lipase pancreatin on fecal fat, neutral sterol, bile acid, and short-chain fatty acid excretion in patients with pancreatic insufficiency resulting from chronic pancreatitis.

Authors:  T Nakamura; Y Tandoh; A Terada; N Yamada; T Watanabe; A Kaji; K Imamura; H Kikuchi; T Suda
Journal:  Int J Pancreatol       Date:  1998-02

5.  Steatorrhea in Japanese patients with chronic pancreatitis.

Authors:  T Nakamura; K Takebe; K Kudoh; M Ishii; K Iamura; H Kikuchi; F Kasai; Y Tandoh; N Yamada; Y Arai
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

6.  Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis.

Authors:  T I Nilsen; L J Vatten
Journal:  Br J Cancer       Date:  2001-02-02       Impact factor: 7.640

7.  Decreased Physiological Serum Total Bile Acid Concentrations in Patients with Type 2 Diabetic Peripheral Neuropathy.

Authors:  Pijun Yan; Qin Wan; Zhihong Zhang; Qian Tang; Yuru Wu; Yong Xu; Ying Miao; Huan Zhao; Ran Liu
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-28       Impact factor: 3.168

8.  Associations of chronic diarrhoea with non-alcoholic fatty liver disease and obesity-related disorders among US adults.

Authors:  Andrea Shin; Huiping Xu; Thomas F Imperiale
Journal:  BMJ Open Gastroenterol       Date:  2019-08-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.